Castle Biosciences (CSTL) Goodwill & Intangibles (2018 - 2026)

Castle Biosciences has disclosed Goodwill & Intangibles across 7 years of filings, most recently posting $95.1 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles fell 8.67% year-over-year to $95.1 million; the TTM figure through Jun 2026 stood at $95.1 million (down 8.67% YoY), while the FY2025 annual figure was $99.6 million, down 6.26% from the prior year.
• Goodwill & Intangibles came in at $95.1 million for Q2 2026 at Castle Biosciences, down from $97.3 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $132.7 million in Q2 2022 to a low of $77.9 million in Q1 2025.
• Average Goodwill & Intangibles over 5 years is $110.0 million, with a median of $111.7 million recorded in 2024.
• Year-over-year, Goodwill & Intangibles soared 306.05% in 2022 and plunged 32.31% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $126.3 million in 2022, then declined by 7.13% to $117.3 million in 2023, then retreated by 9.47% to $106.2 million in 2024, then decreased by 6.26% to $99.6 million in 2025, then retreated by 4.5% to $95.1 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $95.1 million in Q2 2026, $97.3 million in Q1 2026, and $99.6 million in Q4 2025.